The Board of Directors of the Coalition for the Advancement of Medical Research (CAMR) announced today that they have voted to dissolve the organization.
CAMR is effectively at an end.
The CAMR Board has decided, as described in an email, to “transfer its mission and its resources to an outstanding colleague organization, the Alliance for Regenerative Medicine (ARM).”
The press release (PR) from CAMR does not clearly articulate a specific reason for dissolving itself.
In the PR, CAMR president Amy Comstock Rick, J.D, is quoted as follows:
“Human embryonic stem cell research has grown and evolved to a point where it’s time for CAMR to hand off its mission to an organization that can advance policy initiatives to support where the science is now, and where it is headed”
I plan to comment on my thoughts on this development in a blog post later in the week.
This is a big shock for the stem cell field that such a wonderful and still highly relevant organization such as CAMR, after more than a decade of extremely important accomplishments for medical research and stem cells, would choose this particular time to put an end to itself. Another important question is how this event will impact ARM and its mission.
Michael Werner, J.D., executive director of ARM, says in the PR:
“In Washington, D.C., and around the world, researchers and policymakers alike have CAMR leadership and its members to thank for the federal funding guidelines that have helped foster an environment for advances in stem cell research in the past 12 years…We are honored to take on CAMR’s mission, meld it with our own, and continue to support the great science that is already contributing to live-giving advances in regenerative medicine.”
I’d value the reaction of readers to this startling development. Please comment.